Lisinopril
- Product NDC
- 53217-253
- 11-digit product format
- 532170253
- Labeler code
- 53217
- Product ID
- 53217-253_069bd16d-3af5-4385-8843-f079cd0f6e85
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Lisinopril
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Aidarex Pharmaceuticals LLC
- Application
- ANDA076063
- Marketing category
- ANDA
- Marketing start
- 2013-02-13
- Marketing end
- 0000-00-00
- Substance
- LISINOPRIL
- Active strength
- 20 mg/1
- Pharmacologic classes
- Angiotensin Converting Enzyme Inhibitor [EPC],Angiotensin-converting Enzyme Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2019-12-31
- Current FDA listing
- Historical FDA.report record
DailyMed Product Concepts#
FDA-Initiated Inactive NDC Indexing#
NDC, Effective, Action table| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|
| 53217-253-02 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d1-11b8-f424-e053-dadaa90a57ce | These highlights do not include all the information needed to use LISINOPRIL TABLETS, USP safely and effectively. See full prescribing information for LISINOPRIL TABLETS, USP . LISINOPRIL tablets , for oral use Initial U.S. Approval: 1988 |
| 53217-253-30 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d1-11b8-f424-e053-dadaa90a57ce | These highlights do not include all the information needed to use LISINOPRIL TABLETS, USP safely and effectively. See full prescribing information for LISINOPRIL TABLETS, USP . LISINOPRIL tablets , for oral use Initial U.S. Approval: 1988 |
| 53217-253-60 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d1-11b8-f424-e053-dadaa90a57ce | These highlights do not include all the information needed to use LISINOPRIL TABLETS, USP safely and effectively. See full prescribing information for LISINOPRIL TABLETS, USP . LISINOPRIL tablets , for oral use Initial U.S. Approval: 1988 |
| 53217-253-90 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d1-11b8-f424-e053-dadaa90a57ce | These highlights do not include all the information needed to use LISINOPRIL TABLETS, USP safely and effectively. See full prescribing information for LISINOPRIL TABLETS, USP . LISINOPRIL tablets , for oral use Initial U.S. Approval: 1988 |
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 53217-253-02 | Lisinopril | 120 in 1 BOTTLE | TABLET | 120 | | 1 |
| 53217-253-30 | Lisinopril | 30 in 1 BOTTLE | TABLET | 30 | | 1 |
| 53217-253-60 | Lisinopril | 60 in 1 BOTTLE | TABLET | 60 | | 1 |
| 53217-253-90 | Lisinopril | 90 in 1 BOTTLE | TABLET | 90 | | 1 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 53217-253 | LISINOPRIL TABLET [AIDAREX PHARMACEUTICALS LLC] | 1 | Legacy NDC, 4 package rows | 20161111_bb6ec726-a143-4811-be3c-1a404459dee6.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Status |
|---|
| 53217-253-02 | 53217025302 | 120 in 1 BOTTLE | Historical |
| 53217-253-30 | 53217025330 | 30 in 1 BOTTLE | Historical |
| 53217-253-60 | 53217025360 | 60 in 1 BOTTLE | Historical |
| 53217-253-90 | 53217025390 | 90 in 1 BOTTLE | Historical |